Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes

Demaria, 2005, Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer, Clin Cancer Res, 11, 728, 10.1158/1078-0432.728.11.2 Sansoni, 1993, Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians, Blood, 82, 2767, 10.1182/blood.V82.9.2767.2767 Campian, 2013, The association between severe treatment-related lymphopenia and progression free survival in patients with newly diagnosed squamous cell head and neck cancer, Head Neck Campian, 2013, Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer, Cancer Invest, 31, 183, 10.3109/07357907.2013.767342 Stanley, 1980, Prognostic factors for survival in patients with inoperable lung cancer, J Natl Cancer Inst, 65, 25 Grossman, 2011, Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide, Clin Cancer Res, 17, 5473, 10.1158/1078-0432.CCR-11-0774 Formenti, 2013, Combining radiotherapy and cancer immunotherapy: A paradigm shift, J Natl Cancer Inst, 105, 256, 10.1093/jnci/djs629 Sellins, 1987, Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes, J Immunol, 139, 3199, 10.4049/jimmunol.139.10.3199 Stratton, 1975, A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients, J Clin Invest, 56, 88, 10.1172/JCI108084 Trowell, 1952, The sensitivity of lymphocytes to ionising radiation, J Pathol Bacteriol, 64, 687, 10.1002/path.1700640403 Yovino, 2013, The etiology of treatment-related lymphopenia in patients with malignant gliomas: Modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells, Cancer Invest, 31, 140, 10.3109/07357907.2012.762780 Yoshida, 1998, Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer, Ann Surg, 227, 485, 10.1097/00000658-199804000-00006 Kobayashi, 2012, Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer, Lung Cancer, 75, 223, 10.1016/j.lungcan.2011.06.009 McCoy, 2012, Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies, Br J Cancer, 107, 1107, 10.1038/bjc.2012.362 Vigano, 2000, Clinical survival predictors in patients with advanced cancer, Arch Intern Med, 160, 861, 10.1001/archinte.160.6.861 Lee, 2009, Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment, Blood, 114, 589, 10.1182/blood-2009-02-206870 Brody, 2010, In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: A phase I/II study, J Clin Oncol, 28, 4324, 10.1200/JCO.2010.28.9793 Seung, 2012, Phase 1 study of stereotactic body radiotherapy and interleukin-2—tumor and immunological responses, Sci Transl Med, 4, 137, 10.1126/scitranslmed.3003649 Kim, 2012, In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: A phase 1/2 study, Blood, 119, 355, 10.1182/blood-2011-05-355222 Postow, 2012, Immunologic correlates of the abscopal effect in a patient with melanoma, N Engl J Med, 366, 925, 10.1056/NEJMoa1112824 Hiniker, 2012, A systemic complete response of metastatic melanoma to local radiation and immunotherapy, Transl Oncol, 5, 404, 10.1593/tlo.12280 Ruocco, 2012, Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects, J Clin Invest, 122, 3718, 10.1172/JCI61931 Menard, 2008, Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: Surrogate marker of efficacy of tremelimumab?, Clin Cancer Res, 14, 5242, 10.1158/1078-0432.CCR-07-4797 Hiniker, 2012, Abscopal effect in a patient with melanoma, N Engl J Med, 366, 2035, 10.1056/NEJMc1203984